+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Urological Disorders Drugs Market Research Reports

From
Overactive bladder - Pipeline Insight, 2024 - Product Thumbnail Image

Overactive bladder - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
ULTOMIRIS Market Size, Emerging Insight, and Forecast to 2032 - Product Thumbnail Image

ULTOMIRIS Market Size, Emerging Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
Underactive Bladder (UAB)- Epidemiology Forecast-2034 - Product Thumbnail Image

Underactive Bladder (UAB)- Epidemiology Forecast-2034

  • Report
  • December 2024
  • 70 Pages
  • Global
From
Stress Urinary Incontinence - Pipeline Insight, 2024 - Product Thumbnail Image

Stress Urinary Incontinence - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 60 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them. Some of the major players in the Urological Disorders Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less Read more